BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 19, 2026
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

Test may do a better job of targeting women's arrhythmias

Feb. 12, 2009
By Lynn Yoffee
In matters of the heart, it's accepted that men and women can be vastly different. And the more researchers dig into gender anomalies related to cardiac care, the more they realize that treatment practices for women need to change. (Diagnostics & Imaging Week)
Read More

New Gore system reduces risk during carotid artery surgery

Feb. 11, 2009
By Lynn Yoffee
When plaque builds in the carotid arteries, surgeons step in to perform an endarterectomy, angioplasty or stenting to prevent patients from having a stroke. But the procedure itself is tricky and sometimes a piece of the plaque can break away and reach the brain, causing a stroke. (Medical Device Daily)
Read More

Lenetix study to evaluate non-invasive prenatal test

Feb. 10, 2009
By Lynn Yoffee

Test may do a better job of targeting women's arrhythmias

Feb. 9, 2009
By Lynn Yoffee
In matters of the heart, it's accepted that men and women can be vastly different. And the more researchers dig into gender anomalies related to cardiac care, the more they realize that treatment practices for women need to change. (Medical Device Daily)
Read More

AOI Medical poised to debut trio of orthopedics products

Jan. 28, 2009
By Lynn Yoffee

Data looks 'optimistic' for the first device to treat HIV

Jan. 27, 2009
By Lynn Yoffee
It has taken almost a decade of work, but now Aethlon Medical (San Diego) is on the verge of releasing first-in-human study data on its flagship Hemopurifier, the first extracorporeal device to treat HIV infection. (Medical Device Daily)
Read More

Micromem developing magnetic, non-invasive glucose sensor

Jan. 26, 2009
By Lynn Yoffee

SmartOR a help in reducing the dangers of neurosurgery

Jan. 20, 2009
By Lynn Yoffee

1st PAD patient treated with Stereotaxis guidewire system

Jan. 13, 2009
By Lynn Yoffee

Deep brain stimulation quells Parkinson's better than meds

Jan. 8, 2009
By Lynn Yoffee
More evidence has emerged this week that mechanical intervention – specifically deep brain stimulation (DBS) – in Parkinson's disease (PD) to quell the debilitating symptoms outweighs the benefits from currently available medication therapies. (Medical Device Daily)
Read More
Previous 1 2 … 23 24 25 26 27 28 29 30 31 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing